IN2014MN02338A - - Google Patents
Info
- Publication number
- IN2014MN02338A IN2014MN02338A IN2338MUN2014A IN2014MN02338A IN 2014MN02338 A IN2014MN02338 A IN 2014MN02338A IN 2338MUN2014 A IN2338MUN2014 A IN 2338MUN2014A IN 2014MN02338 A IN2014MN02338 A IN 2014MN02338A
- Authority
- IN
- India
- Prior art keywords
- inhibitors
- relates
- present
- tec
- members
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Abstract
The present invention relates to a novel family of inhibitors of protein kinases. In particular the present invention relates to inhibitors of the members of the Tec and Src protein kinase families.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2779184A CA2779184A1 (en) | 2012-05-31 | 2012-05-31 | Protein kinase inhibitors |
CA2813299A CA2813299A1 (en) | 2013-04-17 | 2013-04-17 | Protein kinase inhibitors |
PCT/CA2013/000513 WO2013177668A1 (en) | 2012-05-31 | 2013-05-28 | Protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02338A true IN2014MN02338A (en) | 2015-08-14 |
Family
ID=49672221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2338MUN2014 IN2014MN02338A (en) | 2012-05-31 | 2013-05-28 |
Country Status (11)
Country | Link |
---|---|
US (1) | US9796716B2 (en) |
EP (1) | EP2855484A4 (en) |
JP (1) | JP6175495B2 (en) |
KR (2) | KR101972990B1 (en) |
CN (1) | CN104379586B (en) |
BR (1) | BR112014029718A2 (en) |
CA (1) | CA2874211A1 (en) |
HK (1) | HK1208460A1 (en) |
IN (1) | IN2014MN02338A (en) |
RU (1) | RU2678767C2 (en) |
WO (1) | WO2013177668A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2833867A1 (en) * | 2013-11-21 | 2015-05-21 | Pharmascience Inc. | Protein kinase inhibitors |
CA2834528A1 (en) * | 2013-11-26 | 2015-05-26 | Pharmascience Inc. | Protein kinase inhibitors |
CN106573001B (en) * | 2014-07-07 | 2019-01-29 | 江苏恒瑞医药股份有限公司 | Amino pyridazine ketone compound as kinases inhibitor |
GB201508747D0 (en) * | 2015-05-21 | 2015-07-01 | Univ Edinburgh | Compounds |
EP3337805A4 (en) * | 2015-05-27 | 2019-04-03 | Pharmascience Inc. | Inhibitors of the tec kinase enzyme family |
US10927087B2 (en) | 2015-12-07 | 2021-02-23 | Dic Corporation | Method for producing polymerizable compound |
WO2017134685A2 (en) * | 2016-02-02 | 2017-08-10 | Sun Pharma Advanced Research Company Limited | Novel hydrazino compounds as btk inhibitors |
CN109369654A (en) * | 2018-11-20 | 2019-02-22 | 山东大学 | 1,3- bis- substituted-4-amino Pyrazolopyrimidines and its preparation method and application |
CN111454268B (en) * | 2019-01-18 | 2023-09-08 | 明慧医药(上海)有限公司 | Cyclic molecules as inhibitors of bruton's tyrosine kinase |
WO2023083373A1 (en) * | 2021-11-15 | 2023-05-19 | 微境生物医药科技(上海)有限公司 | Compound used as src inhibitor |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ2002934A3 (en) | 1999-09-17 | 2002-07-17 | Abbott Gmbh & Co. Kg | Kinase inhibitors functioning as therapeutic agents |
US6921763B2 (en) * | 1999-09-17 | 2005-07-26 | Abbott Laboratories | Pyrazolopyrimidines as therapeutic agents |
SK3812002A3 (en) * | 1999-09-17 | 2003-09-11 | Abbott Gmbh & Co Kg | Pyrazolopyrimidines as therapeutic agents |
NZ514403A (en) * | 1999-12-27 | 2002-10-25 | Japan Tobacco Inc | Fused-ring compounds and use thereof as drugs |
AUPR392301A0 (en) | 2001-03-23 | 2001-04-26 | University Of Newcastle Research Associates Limited, The | Protein phosphatase inhibitors |
CA2810339A1 (en) * | 2001-08-10 | 2003-02-20 | Novartis Ag | Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemia |
DK2526933T3 (en) | 2006-09-22 | 2015-05-18 | Pharmacyclics Inc | Inhibitors of Bruton's tyrosine kinase |
CN101674834B (en) * | 2007-03-28 | 2013-06-12 | 环状药物公司 | Inhibitors of bruton's tyrosine kinase |
US7718662B1 (en) * | 2009-10-12 | 2010-05-18 | Pharmacyclics, Inc. | Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase |
PT2488486T (en) * | 2009-10-13 | 2019-11-05 | Ligand Pharm Inc | Hematopoietic growth factor mimetic small molecule compounds and their uses |
CN105408334B (en) * | 2013-05-21 | 2017-10-10 | 江苏迈度药物研发有限公司 | It is used as the substituted Pyrazolopyrimidines of kinase inhibitor |
CN103787839B (en) | 2014-01-21 | 2015-12-02 | 苏州昊帆生物科技有限公司 | The method of synthesis 2,3,4,5,6-Pentafluorophenol |
-
2013
- 2013-05-28 CN CN201380028248.2A patent/CN104379586B/en not_active Expired - Fee Related
- 2013-05-28 KR KR1020147036372A patent/KR101972990B1/en active IP Right Grant
- 2013-05-28 KR KR1020197011438A patent/KR20190043648A/en not_active Application Discontinuation
- 2013-05-28 JP JP2015514295A patent/JP6175495B2/en not_active Expired - Fee Related
- 2013-05-28 EP EP13796590.1A patent/EP2855484A4/en not_active Withdrawn
- 2013-05-28 CA CA2874211A patent/CA2874211A1/en not_active Abandoned
- 2013-05-28 US US14/404,497 patent/US9796716B2/en not_active Expired - Fee Related
- 2013-05-28 IN IN2338MUN2014 patent/IN2014MN02338A/en unknown
- 2013-05-28 WO PCT/CA2013/000513 patent/WO2013177668A1/en active Application Filing
- 2013-05-28 BR BR112014029718A patent/BR112014029718A2/en not_active Application Discontinuation
- 2013-05-28 RU RU2014145285A patent/RU2678767C2/en not_active IP Right Cessation
-
2015
- 2015-09-18 HK HK15109229.7A patent/HK1208460A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2678767C2 (en) | 2019-02-01 |
EP2855484A1 (en) | 2015-04-08 |
US20150191473A1 (en) | 2015-07-09 |
CA2874211A1 (en) | 2013-12-05 |
CN104379586B (en) | 2018-01-16 |
WO2013177668A1 (en) | 2013-12-05 |
EP2855484A4 (en) | 2015-12-16 |
CN104379586A (en) | 2015-02-25 |
KR20190043648A (en) | 2019-04-26 |
RU2014145285A (en) | 2016-07-20 |
KR20150015527A (en) | 2015-02-10 |
BR112014029718A2 (en) | 2017-06-27 |
HK1208460A1 (en) | 2016-03-04 |
US9796716B2 (en) | 2017-10-24 |
JP2015518009A (en) | 2015-06-25 |
KR101972990B1 (en) | 2019-04-26 |
JP6175495B2 (en) | 2017-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02338A (en) | ||
ZA201600648B (en) | Novel pyrrolopyrimidine compounds as inhibitors of protein kinases | |
HK1206298A1 (en) | Compounds useful as inhibitors of atr kinase and combination therapies thereof atr | |
HK1215577A1 (en) | Protein kinase inhibitors | |
HK1212336A1 (en) | Azaquinazoline inhibitors of atypical protein kinase | |
MX355728B (en) | Kinase inhibitors. | |
ZA201405140B (en) | Disubstituted benzothienyl-pyrolotriazines and their use as fgfr kinase inhibitors | |
HK1202333A1 (en) | Combination of kinase inhibitors and uses thereof | |
MX2013011537A (en) | Protein kinase inhibitors. | |
PL2880035T3 (en) | Novel pyrrolopyrimidine compounds as inhibitors of protein kinases | |
EP2833889A4 (en) | Protein kinase c inhibitors and uses thereof | |
HK1209726A1 (en) | Protein kinase inhibitors | |
HK1205506A1 (en) | Protein kinase inhibitors | |
HK1210036A1 (en) | Aminoisoquinoline derivatives as protein kinase inhibitors | |
GB201209458D0 (en) | Novel compounds and their use as kinase inhibitors | |
GB201206048D0 (en) | Novel compounds and their use as kinase inhibitors |